• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析患者的血压与心血管事件及死亡率之间的关联:一项观察性研究的系统评价和荟萃分析

Association between blood pressure and cardiovascular events and mortality in patients on peritoneal dialysis: a systematic review and meta-analysis of observational studies.

作者信息

Bezerra Rodrigo, Teles Flavio, Nadruz Wilson, Feitosa Audes D M, Coelho Jorge A P M, Ponce Daniela, Pecoits-Filho Roberto, Rodrigues Cibele I S

机构信息

Keizo Asami Institute, Federal University of Pernambuco, Recife, PE, Brazil.

Pronto Socorro Cardiológico de Pernambuco (PROCAPE), University of Pernambuco, Rua dos palmares S/N - Santo Amaro, Recife, PE, Brazil.

出版信息

Clin Exp Nephrol. 2025 Jun 22. doi: 10.1007/s10157-025-02719-3.

DOI:10.1007/s10157-025-02719-3
PMID:40545494
Abstract

BACKGROUND

The association between blood pressure (BP) and adverse outcomes in peritoneal dialysis (PD) remains uncertain. This study aims to address this knowledge gap.

MATERIALS AND METHODS

We systematically searched five databases (1964-2025) for observational studies assessing associations between BP and mortality or cardiovascular (CV) outcomes in adults on PD. Risk of bias was evaluated using the Newcastle-Ottawa Scale and ROBINS-I. Meta-analyses were performed using random- or fixed-effects models, and pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for continuous and categorical BP exposures.

RESULTS

Twenty-four studies comprising 28,016 patients (55% males; hypertension prevalence ranging from 39 to 95%) were included. Higher pulse pressure (PP) was consistently associated with increased all-cause (HR per 10 mmHg: 1.20; 95%CI 1.02-1.40) and CV (HR per 10 mmHg: 1.35; 95%CI 1.16-1.58) mortality. For systolic BP (SBP), no significant association was found when analyzed as a continuous variable. However, predefined thresholds revealed that all-cause mortality was significantly associated with SBP < 120 mmHg (HR: 1.55; 95%CI 1.15-2.11) and with SBP > 140 mmHg (HR: 1.18; 95%CI 1.07-1.31). Diastolic BP was not significantly associated with mortality. Additional studies linked higher BP to left ventricular hypertrophy and non-fatal CV events.

CONCLUSION

In PD patients, SBP < 120 mmHg and > 140 mmHg are associated with increased all-cause mortality, while elevated PP robustly predicts all-cause and CV mortality. These findings identify SBP and PP as key prognostic markers and potential targets in PD management.

摘要

背景

血压(BP)与腹膜透析(PD)不良结局之间的关联仍不确定。本研究旨在填补这一知识空白。

材料与方法

我们系统检索了五个数据库(1964 - 2025年),以查找评估成人PD患者血压与死亡率或心血管(CV)结局之间关联的观察性研究。使用纽卡斯尔 - 渥太华量表和ROBINS - I评估偏倚风险。采用随机效应或固定效应模型进行荟萃分析,并针对连续性和分类性血压暴露计算合并风险比(HRs)及95%置信区间(CIs)。

结果

纳入了24项研究,共28016例患者(55%为男性;高血压患病率为39%至95%)。较高的脉压(PP)始终与全因死亡率增加(每10 mmHg的HR:1.20;95%CI 1.02 - 1.40)和心血管死亡率增加(每10 mmHg的HR:1.35;95%CI 1.16 - 1.58)相关。对于收缩压(SBP),作为连续变量分析时未发现显著关联。然而,预定义阈值显示,全因死亡率与SBP < 120 mmHg(HR:1.55;95%CI 1.15 - 2.11)以及SBP > 140 mmHg(HR:1.18;95%CI 1.07 - 1.31)显著相关。舒张压与死亡率无显著关联。其他研究将较高血压与左心室肥厚和非致命性心血管事件联系起来。

结论

在PD患者中,SBP < 120 mmHg和> 140 mmHg与全因死亡率增加相关,而升高的PP有力地预测全因死亡率和心血管死亡率。这些发现确定SBP和PP为PD管理中的关键预后标志物和潜在靶点。

相似文献

1
Association between blood pressure and cardiovascular events and mortality in patients on peritoneal dialysis: a systematic review and meta-analysis of observational studies.腹膜透析患者的血压与心血管事件及死亡率之间的关联:一项观察性研究的系统评价和荟萃分析
Clin Exp Nephrol. 2025 Jun 22. doi: 10.1007/s10157-025-02719-3.
2
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
3
Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.基于手机的干预措施,用于提高成年人心血管疾病一级预防中所开药物的依从性。
Cochrane Database Syst Rev. 2018 Jun 22;6(6):CD012675. doi: 10.1002/14651858.CD012675.pub2.
4
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
5
Renal denervation for resistant hypertension.肾去神经术治疗顽固性高血压。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD011499. doi: 10.1002/14651858.CD011499.pub2.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Blood pressure lowering efficacy of renin inhibitors for primary hypertension.肾素抑制剂对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2017 Apr 5;4(4):CD007066. doi: 10.1002/14651858.CD007066.pub3.
8
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
9
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.用于预防动脉粥样硬化性心血管疾病的固定剂量联合疗法。
Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3.
10
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.

本文引用的文献

1
Associations of Glucometabolic Indices with Aortic Stiffness in Patients Undergoing Peritoneal Dialysis with and without Diabetes Mellitus.糖代谢指标与合并或不合并糖尿病的腹膜透析患者的主动脉僵硬度的相关性。
Int J Mol Sci. 2023 Dec 4;24(23):17094. doi: 10.3390/ijms242317094.
2
Long-term blood pressure variability and frailty risk in older adults.老年人长期血压变异性与虚弱风险。
J Hypertens. 2024 Feb 1;42(2):244-251. doi: 10.1097/HJH.0000000000003599. Epub 2023 Nov 20.
3
Home Pulse Pressure Predicts Death and Cardiovascular Events in Peritoneal Dialysis Patients.
家庭脉压可预测腹膜透析患者的死亡和心血管事件。
J Clin Med. 2023 Jun 7;12(12):3904. doi: 10.3390/jcm12123904.
4
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
5
Epidemiology of Hypertension among Patients on Peritoneal Dialysis Using Standardized Office and Ambulatory Blood Pressure Recordings.腹膜透析患者标准化诊室和动态血压记录的高血压流行病学。
Am J Nephrol. 2022;53(2-3):139-147. doi: 10.1159/000521861. Epub 2022 Feb 4.
6
Volume status and arterial stiffness evaluation in peritoneal dialysis patients.腹膜透析患者的容量状态和动脉僵硬评估。
Clin Nephrol. 2021;96(1):74-79. doi: 10.5414/CNP96S13.
7
The Relation of Clinic and Ambulatory BP with the Risk of Cardiovascular Events and All-Cause Mortality among Patients on Peritoneal Dialysis.腹膜透析患者临床血压和动态血压与心血管事件风险及全因死亡率的关系
J Clin Med. 2021 May 21;10(11):2232. doi: 10.3390/jcm10112232.
8
Prediction of premature all-cause mortality in patients receiving peritoneal dialysis using modified artificial neural networks.应用改良人工神经网络预测腹膜透析患者的全因过早死亡。
Aging (Albany NY). 2021 May 13;13(10):14170-14184. doi: 10.18632/aging.203033.
9
Association of Ambulatory Blood Pressure with All-Cause Mortality and Cardiovascular Outcomes in Peritoneal Dialysis Patients.动态血压与腹膜透析患者全因死亡率及心血管结局的关系。
Kidney Blood Press Res. 2020;45(6):890-899. doi: 10.1159/000510298. Epub 2020 Dec 2.
10
The associations of blood pressure parameters with all-cause and cardiovascular mortality in peritoneal dialysis patients: a cohort study in China.在中国的一项队列研究中,腹膜透析患者的血压参数与全因和心血管死亡率的相关性。
J Hypertens. 2020 Nov;38(11):2252-2260. doi: 10.1097/HJH.0000000000002526.